N/A N=80 FLOW-AF: A Study to Evaluate Electrographic Flow™ (EGF) Mapping Technology
Atrial Fibrillation, Persistent
Primary: Number of Participants With Acute Procedure Success — 19 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=176 Navigation vs Usual Care for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC
Squamous Cell Carcinoma of Head and Neck
Primary: Delay Initiating Postoperative Radiation Therapy (PORT) — 14; 46 Participants
N/A N=82 Thulium vs. Hol:YAG Laser
Nephrolithiasis
Primary: Number of Participants With Stone Free Status — 27; 26 Participants
N/A N=25 MONOVISC for Shoulder Joint Pain Relief Due to Osteoarthritis
Osteo Arthritis Shoulders
Primary: Numerical Rating Scale (NRS) Pain — -4.12 score on a scale — p=<0.0001
Phase 4 N=33 Effects of Isotretinoin on CYP2D6 Activity
CYP2D6 Polymorphism
Primary: CYP2D6 Activity as Measured by the Molar Concentration Ratio of Dextromethorphan (DM)/Dextrophan (DX) — 16.0; 12.5 Ratio
N/A N=25 MONOVISC for Ankle Joint Pain Relief Due to Osteoarthritis
Osteoarthritis Ankle
Primary: Numerical Rating Scale (NRS) Pain on Walking — -3.00 score on a scale — p=<0.0001
N/A N=25 Living With Multimorbidity: CO-ORDINATE Program
Multimorbidity · Quality of Life · Symptom Management
Primary: Symptom Burden Assessed by Edmonton Symptom Assessment System (ESAS) Score - Pain — 5; 4; 5 score on a scale
N/A N=25 MONOVISC for Hip Joint Pain Relief Due to Osteoarthritis
Osteoarthritis, Hip
Primary: Numerical Rating Scale (NRS) Pain on Walking — -3.68 score on a scale — p=<0.0001
N/A N=48 EmoLED Medical Device Treatment of Second and Third Stage Pressure Ulcers
Pressure Sore · Pressure Ulcer · Pressure Ulcers Stage III
Primary: Percentage Difference in PUSH Score — 23.1; 39.1 percentage reduction of PUSH score
Phase 2 N=59 Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
Microsatellite Stable (MSS) Colorectal Adenocarcinomas · Colorectal Adenocarcinoma
Primary: Objective Response Rate (ORR) — 0; 1; 2 Participants
N/A N=250 Calcium: Magnesium Balance, Microbiota, and Necroptosis and Inflammation
Colorectal Cancer
Primary: Comparisons of the Changes of Genera Prevotella by Mg Treatment vs. Placebo in Rectal Mucosa, Swab and Stool Samples — 0.108; 0.245; -0.076; 0.132 percentage of sample…
Phase 2 N=22 Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M
Non-Small Cell Lung Cancer
Primary: Objective Response Rate (ORR) — 77.3 percentage of patients
Phase 2 N=20 Anakinra for the Reduction of CAR-T Toxicity in Patients With Relapsed or Refractory Large B-cell Lymphoma
Hematopoietic and Lymphoid Cell Neoplasm · Recurrent Diffuse Large B-Cell Lymphoma · Recurrent High Grade B-Cell Lymphoma
Primary: Incidence of Any Grade Cytokine Release Syndrome (CRS) — 10; 9 Participants
Phase 2 N=64 Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma
Hematopoietic Cell Transplantation Recipient · Plasma Cell Myeloma
Primary: Progression-free Survival — 73.3 Months
N/A N=74 Intranasal Oxytocin and Maternal Neglect
Maternal Behavior
Primary: Differences in Brain Activation (Blood Oxygen Level Dependent [BOLD] Signal) of Dopamine Reward Regions and Prefrontal Cortex After Intranasal Oxytocin Administration in…